Eastman Kodak CompanyKODKNYSE
Loading
Eastman Kodak is a legacy imaging company that has pivoted from consumer film to industrial printing, advanced materials, and specialty chemicals. The company operates printing systems for commercial and packaging markets, produces specialty chemicals for pharmaceutical and industrial applications, and manufactures film for motion pictures. With $1.0B in revenue and negative free cash flow, Kodak is a restructured entity trading at distressed valuations (0.6x sales, 0.8x book) as it attempts to stabilize declining revenues in mature printing markets.
Kodak generates revenue through equipment sales with recurring consumables (inks, plates, chemistry) creating an installed base model in printing. The Advanced Materials segment sells specialty chemicals with long-term supply contracts to pharmaceutical and industrial customers. Film revenue comes from being the last major supplier of motion picture film to studios that prefer analog formats. Gross margins of 19.5% reflect commodity-like pricing in mature markets with limited differentiation. Operating margins are slightly negative (-0.7%) indicating the company is still restructuring fixed costs from its legacy infrastructure.
Print Systems order flow and installed base growth in packaging markets (corrugated, flexible packaging)
Advanced Materials contract wins with pharmaceutical customers and specialty chemical pricing
Restructuring announcements and cost reduction initiatives to reach sustainable profitability
Balance sheet concerns including liquidity position, pension funding status, and debt covenant compliance
Speculative trading activity given low float and distressed valuation multiples
Secular decline in commercial printing as digital media replaces print advertising and publishing
Technological obsolescence risk as digital printing technologies from HP, Canon, and Xerox continue advancing
Motion picture film market shrinking as studios increasingly adopt digital cinematography
Legacy pension and OPEB obligations from historical workforce creating ongoing cash drain
Intense competition in digital printing from HP Indigo, Canon, Xerox, and Ricoh with superior R&D budgets
Specialty chemicals competitors (BASF, Dow, Eastman Chemical) have scale advantages and broader portfolios
Limited pricing power in commoditized printing consumables markets
Customer concentration risk in pharmaceutical intermediates and motion picture film
Negative free cash flow of -$0.1B indicates ongoing cash burn requiring external financing
Current ratio of 0.79 signals working capital stress and potential liquidity constraints
Debt refinancing risk given distressed operating performance and limited asset coverage
Pension underfunding requiring ongoing contributions that consume operating cash flow
high - Print Systems revenue is highly cyclical, tied to commercial printing volumes, packaging demand, and capital equipment spending by print shops. Economic downturns reduce advertising spending and packaging volumes. Advanced Materials has moderate cyclicality through pharmaceutical and industrial end markets. The company's negative operating margins amplify sensitivity to revenue declines.
Rising rates negatively impact Kodak through higher borrowing costs on its debt (0.64 D/E ratio) and reduced capital equipment spending by customers who finance purchases. Lower rates would ease refinancing pressure and support customer equipment investments. The company's distressed valuation makes it sensitive to risk-off environments when rates rise rapidly.
High credit exposure given negative free cash flow, below-investment-grade credit profile, and reliance on working capital facilities. Tightening credit conditions could restrict access to liquidity and increase borrowing costs. Customers' ability to finance equipment purchases depends on credit availability.
value - Distressed valuation multiples (0.6x sales, 0.8x book) attract deep value investors betting on turnaround execution. Some speculative/momentum traders drawn to low float and volatility. Not suitable for growth or dividend investors given declining revenues and no dividend. Requires high risk tolerance for potential bankruptcy or restructuring scenarios.
high - Small market cap ($0.6B), low trading liquidity, and distressed fundamentals create high volatility. Stock is sensitive to restructuring announcements, liquidity concerns, and speculative trading. Beta likely exceeds 1.5x given operational and financial leverage.